MOSCHETTA, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 9.879
EU - Europa 1.971
AS - Asia 821
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
Totale 12.683
Nazione #
US - Stati Uniti d'America 9.875
CN - Cina 695
SE - Svezia 631
IT - Italia 470
DE - Germania 208
UA - Ucraina 196
GB - Regno Unito 166
FI - Finlandia 151
FR - Francia 42
SG - Singapore 40
IE - Irlanda 34
VN - Vietnam 34
BE - Belgio 28
IN - India 17
RU - Federazione Russa 15
NL - Olanda 14
CZ - Repubblica Ceca 9
HK - Hong Kong 7
BR - Brasile 6
JP - Giappone 5
TR - Turchia 5
CA - Canada 4
IR - Iran 4
CO - Colombia 3
ID - Indonesia 3
BD - Bangladesh 2
EU - Europa 2
KR - Corea 2
PL - Polonia 2
CH - Svizzera 1
DZ - Algeria 1
ES - Italia 1
GE - Georgia 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MM - Myanmar 1
MY - Malesia 1
PK - Pakistan 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
Totale 12.683
Città #
Fairfield 1.653
Woodbridge 1.136
Houston 792
Ashburn 761
Chandler 751
Seattle 606
Cambridge 602
Wilmington 530
Nyköping 509
Jacksonville 476
Ann Arbor 464
Lawrence 194
Roxbury 188
Nanjing 181
Bari 167
Beijing 131
New York 126
Dearborn 125
Des Moines 109
Inglewood 97
Princeton 89
San Diego 75
Boardman 55
Shenyang 48
Hebei 43
Brooklyn 37
San Giovanni Teatino 37
London 36
Dong Ket 34
Dublin 34
Jiaxing 33
Nanchang 32
Brussels 27
Los Angeles 25
Cressa 24
Tianjin 22
Guangzhou 21
Hefei 19
Changsha 18
Redwood City 17
Paris 16
Singapore 16
Jinan 15
Kunming 14
Helsinki 13
Indianapolis 13
Pune 10
Brno 9
Cerignola 9
Ningbo 8
San Mateo 8
Wuhan 8
Hounslow 7
Norwalk 7
Zhengzhou 7
Hong Kong 6
Rome 6
Shanghai 6
Acton 5
Catania 5
Chiswick 5
Jinhua 5
Lubbock 5
Munich 5
Ostuni 5
Prescot 5
Toyonaka 5
Andria 4
Brescia 4
Pescara 4
Stimigliano 4
Taizhou 4
Toronto 4
Auburn Hills 3
Baotou 3
Fuzhou 3
Gioia Del Colle 3
Haikou 3
Herbolzheim 3
Imbersago 3
Indiana 3
Kilburn 3
Leeds 3
Marseille 3
Milan 3
Modugno 3
Mumbai 3
Parrish 3
Perugia 3
Philadelphia 3
Shenzhen 3
Tappahannock 3
Torrile 3
Yiwu 3
Alfonsine 2
Altamura 2
Ardabil 2
Augusta 2
Bisceglie 2
Boydton 2
Totale 10.646
Nome #
Deletion of Stearoyl-CoA Desaturase-1 From the Intestinal Epithelium Promotes Inflammation and Tumorigenesis, Reversed by Dietary Oleate 124
The gut-liver axis in hepatocarcinoma: a focus on the nuclear receptor FXR and the enterokine FGF19 119
Basolateral Ca2+-dependent K+-channels play a key role in Cl- secretion induced by taurodeoxycholate from colon mucosa 118
TRIM8 restores p53 tumour suppressor function by blunting N-MYC activity in chemo-resistant tumours 118
Metabolic aspects in NAFLD, NASH and hepatocellular carcinoma: the role of PGC1 coactivators 115
Nuclear receptor FXR, bile acids and liver damage: Introducing the progressive familial intrahepatic cholestasis with FXR mutations 114
Genes and miRNA expression signatures in peripheral blood mononuclear cells in healthy subjects and patients with metabolic syndrome after acute intake of extra virgin olive oil 114
Nuclear receptors in regenerating liver and hepatocellular carcinoma 113
Atherosclerosis: lessons from LXR and the intestine. 112
Is hepatic lipogenesis fundamental for NAFLD/NASH? A focus on the nuclear receptor coactivator PGC-1β 112
Uncoupling FoxO3A mitochondrial and nuclear functions in cancer cells undergoing metabolic stress and chemotherapy. 112
Role of oleic acid in the gut-liver axis: From diet to the regulation of its synthesis via Stearoyl-CoA desaturase 1 (SCD1) 110
Integrative miRNA and Whole-Genome Analyses of Epicardial Adipose Tissue in Patients with Coronary Atherosclerosis 107
Casting a shadow on liver X receptor-mediated atheroprotection: is LXRβ to blame? 105
Down-regulation of the LXR transcriptome provides the requisite cholesterol levels to proliferating hepatocytes 104
Sindrome metabolica e lavoro 104
Hepatic microRNA Expression by PGC-1α and PGC-1β in the Mouse 104
Modulation of cholesterol crystallization in bile. Implications for non-surgical treatment of cholesterol gallstone disease. 103
Bile acids lower triglyceride levels via a pathway involving FXR, SHP and SREBP1c 102
Activation of LXRs prevents bile acid toxicity and cholestasis in female mice 102
Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23 99
Water handling and aquaporins in bile formation: recent advances and research trends 99
Adenomatous polyposis coli (APC)-induced apoptosis of HT29 colorectal cancer cells depends on mitochondrial oxidative metabolism 98
Effect of hydrosoluble vitamin E on erythrocyte membrane lipid composition in patients with advanced cirrhosis: An open-label pilot trial. 97
Hepatic peroxisome proliferator‐activated receptor γ coactivator 1β drives mitochondrial and anabolic signatures that contribute to hepatocellular carcinoma progression in mice 97
Expression and localisation of insulin receptor substrate 2 in normal intestine and colorectal tumours. Regulation by intestine-specific transcription factor CDX2 97
The "hemolysis model" for the study of cyto-toxicity and cyto-protection by bile salts and phospholipids 96
Hepatic-specific PPARa-FGF21 action in NAFLD 95
Nuclear receptors expression chart in peripheral blood mononuclear cells identifies patients with Metabolic Syndrome. 93
Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis 93
Integrative genetic, epigenetic and pathological analysis of paraganglioma reveals complex dysregulation of NOTCH signaling 93
Pathophysiology of cholesterol gallstone disease 92
Welcoming Foxa2 in the bile acid entourage 92
FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption 91
Clustering nuclear receptors in liver regeneration identifies candidate modulators of hepatocyte proliferation and hepatocarcinoma. 91
Master regulation of bile acid and xenobiotic metabolism via the FXR, PXR and CAR trio 91
The FXR-FGF19 Gut-Liver Axis as a Novel "hepatostat" 91
Intestinal ecology in the metabolic syndrome 91
SEL1L, an UPR response protein, a potential marker of colonic cell transformation. 91
PGC-1α induced browning promotes involution and inhibits lactation in mammary glands 91
Lipid-sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndrome 89
Biliary Phospholipids Sustain Enterocyte Proliferation and Intestinal Tumor Progression via Nuclear Receptor Lrh1 in mice 89
null 88
Preface: a special issue on nuclear receptors with a special view on the molecular basis of disease. 87
Intestinal specific LXR activation stimulates reverse cholesterol transport and protects from atherosclerosis 86
Uncoupling nuclear receptor LXR and cholesterol metabolism in cancer 85
A Novel Protective Role for FXR against Inflammasome Activation and Endotoxemia 85
Aminotransferase activity in morbid and uncomplicated obesity: Predictive role of fasting insulin 85
The emerging discipline of precision cooking: a suitable tool for the precision nutrition 85
Extra virgin olive oil: Lesson from nutrigenomics 85
The Intestinal Nuclear Receptor Signature With Epithelial Localization Patterns and Expression Modulation in Tumors 85
Bile acids and colon cancer: Solving the puzzle with nuclear receptors 84
Interleukins 1 beta and 6 induce functional alteration of rat colonic motility: an in vitro study 83
Changes of gallbladder and gastric dynamics in patients with acute hepatitis A 83
The European accreditation of Istituto Tumori Giovanni Paolo II of Bari 83
Hepatic Niemann Pick C1-like 1: the canalicular side of the coin 82
Primary sclerosing cholangitis: updates in diagnosis and therapy. 82
A phylogenetic survey of biliary lipids in vertebrates 81
Linking transcription to physiology in lipidomics 81
null 81
null 80
LXRs, SHP, and FXR in Prostate Cancer: Enemies or Ménage à Quatre With AR? 80
Intestinal nuclear receptors in HDL cholesterol metabolism. 80
Parallel intestinal and liver injury during early cholestasis in the rat: modulation by bile salts and antioxidants 79
Mitochondrial function - gatekeeper of intestinal epithelial cell homeostasis 79
Effects of hydrophobic and hydrophilic bile salt mixtures on cholesterol crystallization in model biles 78
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis 78
A translational view on the biliary lipid secretory network 78
Nuclear receptors and cholesterol metabolism in the intestine 78
Exploration of Inflammatory Bowel Disease in Mice: Chemically Induced Murine Models of Inflammatory Bowel Disease (IBD) 78
Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease 78
Liver X Receptors Inhibit Proliferation of Human Colorectal Cancer Cells and Growth of Intestinal Tumors in Mice 78
Selective Activation of Nuclear Bile Acid Receptor FXR in the Intestine Protects Mice Against Cholestasis. 78
Nuclear bile acid receptor FXR protects against intestinal tumorigenesis 77
Nuclear receptors, intestinal architecture and colon cancer: an intriguing link 77
Micellar lipid composition profoundly affects LXR-dependent cholesterol transport across CaCo2 cells 77
Taurodeoxycholate-induced intestinal injury is modulated by oxidative stress-dependent pre-conditioning like mechanisms 77
null 76
Nuclear bile acid receptor FXR as pharmacological target: are we there yet? 76
Taurodeoxycholate cytotoxic and sphingomyelin protective effects in isolated human colon mucosa 75
Potential role of the vitamin D receptor in control of cholesterol levels. 75
PGC-1β Induces Susceptibility To Acetaminophen-Driven Acute Liver Failure 75
Liver X Receptor Regulates Triglyceride Absorption Through Intestinal Down-regulation of Scavenger Receptor Class B, Type 1 74
Cholesterol gallstone disease 73
Long-term Administration of Nuclear Bile Acid Receptor FXR Agonist Prevents Spontaneous Hepatocarcinogenesis in Abcb4-/- Mice 73
Neuron-derived orphan receptor 1 promotes proliferation of quiescent hepatocytes 73
Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting ROME II criteria for irritable bowel syndrome. 73
Pathways of cholesterol crystallization in model bile and native bile 72
null 72
Tissue-specific actions of FXR in metabolism and cancer. 72
LA SINDROME METABOLICA NEGLI ADDETTI ALLA PESCA MARITTIMA 72
The insulin receptor substrate 1 (IRS1) in intestinal epithelial differentiation and in colorectal cancer. 71
Pericardial Adipose Tissue Regulates Granulopoiesis, Fibrosis and Cardiac Function After Myocardial Infarction 70
Proteomics for the discovery of nuclear bile acid receptor FXR targets 69
Emerging role of fibroblast growth factors 15/19 and 21 as metabolic integrators in the liver 69
null 68
Coordinate regulation of gallbladder motor function in the gut-liver axis 68
From lipid secretion to cholesterol crystallization in bile. Relevance in cholesterol gallstone disease 68
Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor 68
Severe impairment of postprandial cholecystokinin release and gallbladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR 67
Totale 8.758
Categoria #
all - tutte 58.978
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.978


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.369 529 175 126 312 347 297 395 320 380 148 252 88
2020/20212.306 149 147 155 156 427 119 242 164 185 283 157 122
2021/20221.594 148 187 31 65 59 191 51 90 113 125 236 298
2022/20232.176 338 235 143 163 229 309 18 263 350 22 54 52
2023/2024882 53 178 38 53 69 216 37 53 9 29 43 104
2024/202573 73 0 0 0 0 0 0 0 0 0 0 0
Totale 13.312